Management of immune thrombocytopenic purpura in pregnancy

Obstetrical and Gynecological Survey

Volumn 63, Issue 3, 2008, Pages 182-188

  Sukenik Halevy, R ^a   Ellis, M H ^a,b   Fejgin, M D ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RHESUS D ANTIBODY; RITUXIMAB; VINCA ALKALOID;

AUTOIMMUNE DISEASE; BLOOD PLACENTA BARRIER; CHILDBIRTH; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DELIVERY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; EXPERIMENTAL MODEL; FETOMATERNAL TRANSFUSION; FETUS DISEASE; FETUS MORTALITY; HEADACHE; HEMATOLOGIC DISEASE; HEMOLYSIS; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; LABOR; MATERNAL DIABETES MELLITUS; MONOTHERAPY; NONHUMAN; OSTEOPENIA; PREGNANCY; REVIEW; SPLENECTOMY; TERATOGENICITY; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; TREATMENT PLANNING; FEMALE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION;

ADRENAL CORTEX HORMONES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 42449139256     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318164013c     Document Type: Review

References (79)

1. Verdy E, Bessous V, Drefus M, et al. Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost 1997;77:806-807.
2. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-1466.
3. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000;37:275-289.
4. McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2003;103:1364-1369.
5. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
6. Warner MN, Moore JC, Warkentin TE, et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 1999;104:442-447.
7. Godeau B, Fain O, Porcher R, et al. Rituximab is an alternative to splenectomy in adults with chronic immune thrombocytopenic purpura: results of a prospective multicenter prospective phase 2 study. Blood 2006;108:145a.
8. Arnold DM, Dentali F, Crowther M, et al. Systematic review: efficacy and safety of eituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007;146:25-33.
9. Kelton JG. Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 2002;16:43-46.
10. American College of Obstetricians and Gynecologists (ALOG). Thrombocytopenia in Pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); September 12, 1999. ACOG Practice Bulletin 6.
11. Law C, Marcaccio M, Tam P, et al. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;336:1494-1498.
12. Burrous RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990;162:732-734.
13. Won YW, Moon W, Yun YS, et al. Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP). Korean J Intern Med 2005;20:129-134.
14. Fujimura K, Harada Y, Fujimoto T, et al. Nation wide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002;75:426-433.
15. Mc Crae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 1992;80:2697-2714.
16. Ali R, Ozkalemakas F, Ozcelik T, et al. Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes. Ann Hematol 2003;82:348-352.
17. Michel M, Novoa MV, Bussel JB. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Br J Haematol 2003;123:142-146.
18. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-2251.
19. Qstensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.
20. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35:112-121.
21. Sloltenburg-Diniger G, Coupland SE, Holtgrave EA. Developmental malformations of the eye by cyclophosphamide. Neurotoxicology 2001;22:510.
22. Singh S, Sanyal AK. Eye anomalies induced by cyclophosphamide in rat fetuses. Acta Anat (Basel) 1976;94:490-496.
23. Mcclure HM, Wilk AL, Horigan EA, et al. Induction of craniofacial malformations in rhesus monkeys (Macaca mulatta) with cyclophosphamide. Cleft Palate J 1979;16:248-256.
24. Kirshon B, Wasserstrum N, Willis R, et al. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988;72 (3 pt 2):462-464.
25. Paladini D, Vassallo M, D'Armiento MR, et al. Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol 2004;70:99-100.
26. Paskulin GA, Gazzoia Zen PR, de Camargo Pinto LL, et al. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol 2005;73:634-637.
27. Barry C, Davis S, Garrard P, et al. Churg-Strauss disease: deterioration in a twin pregnancy. Successful outcome following treatment with corticosteroids and cyclophosphamide. Br J Obstet Gynaecol 1997;104:746-747.
28. Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc 1979;71:165-166.
29. Murray CL, Reichert JA, Anderson L, et al. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 1984;252:2607-2608.
30. Schardein JL. Chemically Induced Birth Defects. 3rd ed. New York and Basel: Marcel Dekker, Inc., 1985:585.
31. Schmid BP. Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A. Toxicology 1984;31:9-21.
32. Armenti VT, Ahlswede KM, Ahlswede BA, et al. National transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1994;57:502-506.
33. Lamarque V, Leleu MF, Monka C, et al. Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 1997;29:2480.
34. Shaheen FA, Al-Sulaiman MH, Al-Khader AA. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation 1993;56:224-225.
35. Bar Oz B, Hackman R, Einarson T, et al. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-1055.
36. Di Paolo S, Schena A, Morrone LF, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation 2000;69:2049-2054.
37. Marushak A, Weber T, Bock J, et al. Pregnancy following kidney transplantation. Acta Obstet Gynecol Scand 1986;65:557-559.
38. Brown JH, Maxwell AP, McGeown MG. Outcome of pregnancy following renal transplantation. Ir J Med Sci 1991;160:255-256.
39. Bar J, Stahl B, Hod M, et al. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Am J Med Genet A 2003;116:31-36.
40. DeWitte DB, Buick MK, Cyran SE, et al. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984;105:625-628.
41. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol. 1985;92:233-239.
42. Alter BP. Meonatal pancytopenia after maternal azathioprine therapy (letter). J Pediatr 1985;106:691.
43. Coté CJ, Meuwissen HJ, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85:324-328.
44. Herold M, Schnohr S, Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 2001;19:3439.
45. Ojeda-Uribe M, Gilliot C, Jung G, et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 2006;26:252-255.
46. Griffiths J, Sia W, Shapiro AM, et al. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can 2005;27:771-774.
47. Iwase K, Higaki J, Yoon HE, et al. Hand-assisted laparoscopic splenectomy for idiopathic thrombocytopenic purpura during pregnancy. Surg Laparosc Endosc Percutan Tech 2001;11:53-56.
48. Sendag F, Kazandi M, Terek MC. Splenectomy combined with cesarean section in a patient with severe immunological thrombocytopenic purpura refractory to medical therapy. J Obstet Gynaecol Res 2001;27:85-88.
49. Euliano TY, Zumberg MS, Frolich M. Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura. J Clin Anesth 2001;13:313-318.
50. Seminple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev 2002;16:9-12.
51. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 1993;48:781-788.
52. Pachi A, Carapella E, Mazzucconi MG, et al. Autoimmune thrombocytopenic purpura: maternal and fetal disease. Early Hum Dev 1992;29:143-147.
53. Payne SD, Resnik R, Moore TR, et al. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997;177:149-155.
54. Kathryn E, Mittal R, Sigouin C, et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003;102:4306-4311.
55. Ajzenberg N, Dreyfus M, Kaplan C, et al. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood 1998;92:4573-4580.
56. Samuels P, Bussel JB, Braitman LE, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990;323:229-235.
57. Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol 1994;46:87-90.
58. Valat AS, Caulier MT, Devos P, et al. Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br J Haematol 1998;103:397-401.
59. Hohlfeld P, Forestier F, Kaplan C, et al. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood 1994;84:1851-1856.
60. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol. 1990;163 (4 pt 1):1147-1150.
61. Yamada H, Fujimoto S. Perinatal management of idiopathic thrombocytopenic purpura in pregnancy: risk factors for passive immune thrombocytopenia. Ann Hematol 1994;68:39-42.
62. Yamada H, Kato EH, Kobashi G, et al. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Semin Thromb Hemost 1999;25:491-496.
63. Laros RK Jr, Kagan R. Route of delivery for patients with immune thrombocytopenic purpura. Am J Obstet Gynecol. 1984;148:901-908.
64. Cook RL, Miller RC, Katz VL, et al. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991;78:578-583.
65. Christiaens GC, Nieuwenhuis HK, Von dem Borne AE, et al. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990;97:893-898.
66. Kelton JG. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med 1983;99:796-800.
67. Christiens GC, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 1997;90:546-552.
68. Silver RM, Branch DW, Scott JR. Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol 1995;73:479-482.
69. Garmel SH, Craigo SD, Morin LM, et al. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn 1995;15:439-445.
70. Christiaens GC. Immune thrombocytopenic purpura in pregnancy. Baillieres Clin Haematol 1998;11:373-380.
71. Song TB, Lee JY, Kim YH, et al. Low neonatal risk of thrombocytopenia in pregnancy associated with immune thrombocytopenic purpura. Fetal Diagn Ther 1999;14:216-219.
72. Scott JR, Cruikshank DP, Kochenour NK, et al. Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura. Am J Obstet Gynecol 1980;136:495-499.
73. Adams DM, Bussel JB, Druzin ML. Accurate intrapartum estimation of fetal platelet count by fetal scalp sample smear. Am J Perinatol 1994;11:42-50.
74. Peleg D, Hunter SK. Perinatal management of women with immune thrombocytopenic purpura: survey of United States perinatologists. Am J Obstet Gynecol 1999;180:645-649.
75. Devendra K, Koh LP. Pregnancy in women with idiopathic thrombocytopenic purpura. Ann Acad Med Singapore 2002;31:276-280.
76. 3 which was unknown preoperatively. J Clin Anesth 2004;16:51-53.
77. Rasmus KT, Rottman RL, Kotelko DM, et al. Unrecognized thrombocytopenia and regional anesthesia in parturients: a retrospective review. Obstet Gynecol 1989;73:943-946.
78. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3). Anesth Analg 1997;85:305-308.
79. Rolbin SH, Abbott D, Musclow E, et al. Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol 1988;71 (6 pt 1):918-920.